Table 2.
Influences of symptom duration and intensity on the course of IS.
| NDS-0 (IC 95%) | NIHSS-GP (IC 95%) | Plateau duration (min.) (IC 95%) | |
|---|---|---|---|
| Lesion-free TIA (n = 28) | 4.31 (3.6–5.1) | 2.92 (2.1–3.8) | 75.23 (29.6–120.9) |
| TIA with lesion (n = 8) | 8.41 (3.6–13.1) | 4.72 (2.2–7.3) | 442.53 (25.7–859.3) |
| Infarction (n = 118) | 14.71 (12.6–16.8) | 12.12 (10.1–14.1) | 727.53 (609.9–845.1) |
| mRS 0–3 (n = 110) | 84 (6.8–9.2) | 5.55 (4.3–6.6) | 399.16 (296.6–501.6) |
| mRS 4-5 (n = 27) | 19.34 (14.2–24.4) | 17.05 (12.8–21.2) | 931.56 (684.7–1178.2) |
| Death (n = 17) | 31.54 (28.2–34.8) | 24.15 (20.9–27.3) | 13206 (1129.8–1510.2) |